Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: from IR
15
Mar 17, 2009 12:22PM

Mar 17, 2009 12:24PM
3
Mar 17, 2009 12:53PM

I may be wrong but it would certainly seem counter productive to issue a "Final Rejection" that was merely a rejection of certain claims. Otherwise, you would think a Certificate of Issuance would be mailed with modifications in the IFW. I think this is a rejection of the entire '336. I do not put much faith in any appeals process. If they were unable to hash out the particulars up to this point, I find the chances of reversal on appeal to be pretty low. If TPL was unwilling to make modifications, I take that to mean those changes would have greatly reduced the '336's scope. The licensing activity came to a halt for a reason, perhaps most had bet this would be the outcome. The patent landscape has changed quit a bit since the early signings of '06. Somewhere along the way it seems patent holders became the enemy. IMO.

3
Mar 17, 2009 01:03PM

Mar 17, 2009 01:07PM
Share
New Message
Please login to post a reply